ChiCTR2100050587
Untitled Trial
A randomized, double blind, placebo controlled, multicenter clinical study of Jinshuibao in improving the symptoms related to pulmonary and cardiac function of COVID 19 during convalescence
Hubei Provincial Hospital of Traditional Chinese Medicine·Phase 4·Chinese Clinical Trial RegistryCompleted
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Novel Coronavirus Pneumonia (COVID 19)
Sponsor & location
- Primary sponsor
- Hubei Provincial Hospital of Traditional Chinese Medicine
- Location
- China
Timeline & enrollment
- Phase
- Phase 4
- Start date
- N/A
- End date
- Sep 30, 2020
ICD-10 classifications
COVID-19, virus identifiedViral pneumonia, unspecifiedOther viral pneumoniaCOVID-19, virus not identifiedPneumonia in viral diseases classified elsewhere
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100050587
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100050587 through Pure Global AI's free database. This Phase 4 trial is sponsored by Hubei Provincial Hospital of Traditional Chinese Medicine and is currently Completed. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.